Single-use Bioprocessing Systems Market is Expanding Rapidly with Sartorius AG launching BIOSTAT STR Generation 3 with BioBrain to make biopharmaceutical development and production faster and safer

 

Single-use Bioprocessing Systems Market

Single-use bioprocessing systems are designed for faster manufacturing as well as to save floor space. These systems are designed to be used once and thereafter discarded. Generally, these devices are comprised of plastic components that have been sealed and sterilized using gamma radiation. Most single-step bioprocess systems are used by medical facilities for the transportation of biological products and waste materials, such as blood, urine, saliva, urine, blood components, and other. These products are normally shipped in containers that are transported through multiple processes, such as by conveyor and by air. Such containers can be expensive to purchase.

Increasing demand for biopharmaceuticals is expected to drive growth of the global single-use bioprocessing systems market. Biopharmaceuticals are medicinal products manufactured in extracted or semi-synthesized from biological sources such as animals, humans, and microorganisms and are mainly used in drug development or as therapeutic agents such as vaccines, cell therapies, and more. Rising demand for biopharmaceuticals has led to increase in R&D activities. For instance, in December 2020, IDBS, a software informatics solution provider, launched Polar, a new product category that aims to streamline and boost biopharmaceutical developments. Hence, such factors are expected to drive growth of the global single-use bioprocessing systems market. Furthermore, faster implementation of and lower risk of product cross-contamination is expected to propel the global single-use bioprocessing systems market growth in the near future.

Challenges regarding extractable and leachable combined with waste disposable difficulties are expected to hamper the global single-use bioprocessing systems market growth in the near future. However, untapped potential in emerging economies can provide major business opportunities in the global single-use bioprocessing systems market in the near future. Among regions, North America is expected to witness significant growth in the global single-use bioprocessing systems market. This is owing to the presence of large-scale biopharmaceutical manufacturing facilities such as Meissner Filtration Products, Inc., GE Healthcare, and ThermoFisher Scientific in the region. Furthermore, Asia Pacific is expected to register a robust growth rate, owing to rising government initiatives in the field of biopharmaceutical sectors.

Key players involved in the global single-use bioprocessing systems market are Meissner Filtration Products, Inc., Pall Corporation, Sartorius AG, Merck KGaA, Eppendorf AG, Rentschler Biopharma SE, General Electric Company (GE Healthcare), ThermoFisher Scientific, and Corning Inc.

For instance, in March 2020, Sartorius AG launched BIOSTAT STR Generation 3 with BioBrain to make biopharmaceutical development and production faster and safer.       


Comments

Popular posts from this blog

Fitness Equipment Market is doing warm-ups to pull growth-rich opportunities from the growing obesity rates accompanied by the sedentary lifestyles

Pressure Bandages Market : Global Industry Analysis and Opportunity Assessment

Botanical and Plant Derived Drugs Market by Source,Dosage - Global Industry Analysis,Size,Share